Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-09

Clinical Trial Update: NovaTears® Eye Drops Observational Study NT-003

View source ↗

Summary

This document reports the completion of the observational NT-003 study evaluating NovaTears Eye Drops for dry eye syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NovaTears Eye Drops (perfluorohexyloctane)

Snippet

Sponsor: Novaliq GmbH | Conditions: Dry Eye Syndromes | Status: COMPLETED